Syndicate content

Going the extra mile as a corporate citizen

Michael Jarvis's picture

Business Ethics magazine has just released its 100 Best Corporate Citizens for 2006. Although limited to US firms, the list still makes fun reading. Companies that have suffered scandals in the past see efforts to restore the reputations paying off – note Nike rising to #13 in the list. Who was number one? Green Mountain Coffee Roaster of Vermont.

Incubating entrepreneurs

In Chile, a novel training program pairs business-school students with low-income entrepreneurs in a mutually enriching partnership. They have realized that beyond just financing, mentorship and training are sometimes needed for entrepreneurs to get started in the right direction.

Chicago microfinance conference

University of Chicago and Northwestern are teaming teamed up for a solid one day event on April 21st, Microfinance at the Crossroads. An impressive mix of public, private and NGO speakers, including Andre Laude from the IFC. Though I wish they hadn’t divided the breakout sessions into ‘finance’ and ‘impact’ tracks. One of my qualms with microfinance is that people divide it into this pro-poor vs. for-profit dichotomy.

The potential of the Chinese consumer

Morgan Stanley chief economist Stephen Roach discusses some surprising data emerging out of a recent Gallup poll in China. He sees amazing potential - once some key constraints are overcome. Mainly the urban-rural gap and building a new safety net.

Future international business trends

According to the latest McKinsey Global Survey, top global executives believe that the growing number of consumers in emerging markets (and the resulting changing consumer tastes) will be the most important trend for global business during the next five years.

Vaccines for development

Owen Barder has a new short note on vaccines for development. The concise piece discusses important ideas such as performance-based grants, purchasing funds, pooled procurement, and advanced market commitments. Also see Glennerster, Kremer & Williams’ new paper on creating markets for vaccines.